Scarica l'app Stockscreener
0.5252
9.46%
-0.0549
Pre-mercato:
.56
0.0348
+6.63%
Silexion Therapeutics Corp Borsa (SLXN) Ultime notizie
SLXN stock touches 52-week low at $0.55 amid market challenges - Investing.com India
Silexion Therapeutics Stock Trades Higher, Trial Data For Pancreatic Cancer Patients Shows Promise - MSN
A new trading data show Silexion Therapeutics Corp (SLXN) is showing positive returns. - SETE News
In the Green: Silexion Therapeutics Corp (SLXN) Closes at 0.64, Up/Down -16.28 from Previous Day - The Dwinnex
SLXN’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25%, Seeks To Breakeven Next Year - Benzinga
Diabetic Kidney Disease Market Revenue to Expand Significantly - openPR
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Silexion Therapeutics Reports Promising Phase 2 Data for Non-Resectable Pancreatic Cancer Treatment - openPR
Silexion Therapeutics Stock Trades Higher, Trial Data For Pancreatic Cancer Patients Shows Promise - Benzinga
Silexion reports improved outcomes in pancreatic cancer trial - Investing.com
Silexion reports improved outcomes in pancreatic cancer trial - Investing.com India
Silexion Therapeutics announces new findings from Loder trial - TipRanks
Stanrose Mafatlal Investments and Finance Limited (STANROS.BO) Latest Stock News & Headlines - Yahoo Finance
Silexion Therapeutics Announces Significant New Data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer - Business Wire
Silexion Therapeutics sees board member resignation - Investing.com
Silexion Therapeutics Corp Announces Resignation of Ilan Shiloah as Independent Director, Member of Audit Committee, the Compensation Committee, and the Corporate Governance and Nominating Committee - Marketscreener.com
Emerging Precision Oncology Companies Show Promise Following Summit’s Success - Vancity Buzz
Industry Update: 3 Exciting Precision Oncology Players to Watch - openPR
Industry Update: 3 Exciting Precision Oncology Players to Watch - WICZ
'We've run out of money' says bar owner as venue closes after nine months - Liverpool Echo
Symbotic (NASDAQ:SYM) Shares Gap Up to $22.41 - Defense World
Australia's Sims tops benchmark gains on positive FY25 start - XM
The Potential Rise in the Price of Symbotic Inc (SYM) following insiders activity - Knox Daily
Symbotic (NASDAQ:SYM) Stock Price Up 4.9% - Defense World
Supply@ME Capital (LON:SYME) Sets New 1-Year Low at $0.01 - Defense World
SEGULA Technologies inaugurates new USA headquarters and a Technicon Design studio in Troy, Michigan - WV News
Symbotic (NASDAQ:SYM) Trading Up 1.2% - Defense World
Investor’s Delight: E.W. Scripps Co. (SSP) Closes Strong at 1.95, Up 2.63 - The Dwinnex
Is Spyre Therapeutics Inc. (SYRE) positioned for future growth? - SETE News
Does E.W. Scripps Co. (SSP) offer a good opportunity for investors? - SETE News
Symphera Raises €2.4M in Seed Financing - FinSMEs
Silvis Materials Awarded $1 Million NSF SBIR Phase II Grant to Reduce Emissions in Packaging and Building - EIN News
Stock Traders Buy High Volume of Put Options on Symbotic (NASDAQ:SYM) - Defense World
‘He was brilliant’: Shwab Elementary teachers remember student killed in accidental shooting Saturday night - WSMV 4
Symbotic (NASDAQ:SYM) Shares Gap Up to $22.41 - MarketBeat
Do investors need to be concerned about Spyre Therapeutics Inc. (SYRE)? - US Post News
E.W. Scripps Co. (SSP) did well last session? - US Post News
Régis Le Bris explains Sunderland's Jewison Bennette plan after loan disappointment and position switch - Sunderland Echo
Spyre Therapeutics (NASDAQ:SYRE) Stock Price Down 5% - MarketBeat
Daily Market Movement: Spyre Therapeutics Inc. (SYRE) Sees a 3.23 Increase, Closing at 29.36 - The Dwinnex
Synectics says trading is 'significantly ahead' of previous guidance - Proactive Investors USA
Vertical Research slashes price target on Symbotic Inc [SYM] – find out why. - The DBT News
Research reports, insider buys and stellar earnings have these stocks firing - RagingBull
SLXN: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Market Momentum: Silexion Therapeutics Corp (SLXN) Registers a 11.61 Increase, Closing at 0.98 - The Dwinnex
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers - StockTitan
PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers - Yahoo Finance
Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference - GlobeNewswire
Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference - Yahoo Finance
SLXN’s Debt-to-Equity Ratio at 1.32: What It Means for Silexion Therapeutics Corp’s Future - The InvestChronicle
Silexion Therapeutics Corp (SLXN)’s stock decline to 1.46 per share - US Post News
Silexion Therapeutics Corp (SLXN) requires closer examination - US Post News
Company’s Banking Stock: Dissecting a -87.00% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Biomotion Sciences’ Strategic Merger and Corporate Restructuring - TipRanks
Moringa Acquisition Corp Announces Cessation of Ilan Levin as Chief Executive Officer - Marketscreener.com
Analyzing the Impact of Earnings Reports on Biomotion Sciences. Inc. (SLXN) Price Performance - The InvestChronicle
Closing Bell Recap: Biomotion Sciences. (SLXN) Ends at 2.26, Reflecting a 15.90 Upturn - The Dwinnex
BIOMOTION SCIENCES- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
SLXN Stock Price and Chart — NASDAQ:SLXN - TradingView
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination - GlobeNewswire
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination - StockTitan
SLXNSilexion Therapeutics Corp Ordinary Shares Latest Stock News & Market Updates - StockTitan
Macau Stock Soars to All-Time High, Reaching $14.45 - Investing.com
Macau Stock Soars to All-Time High, Reaching $14.45 - Investing.com India
Moringa Acquisition Corp Shareholders Approve Silexion Merger By Investing.com - Investing.com Australia
Macau Stock Soars to All-Time High, Reaching $14.45 By Investing.com - Investing.com UK
Collaborative autism study analyzes movement through computer vision technology - MSN
Moringa Acquisition Corp Shareholders Approve Silexion Merger - Investing.com
0.05%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):